Vaidya Sane Ayurved Laboratories share news, announcements and annual reports

NSE: MADHAVBAUGHealthcare Equipment & Supplies

Vaidya Sane Ayurved Laboratories Limited · Face value ₹10 · Listed Feb 2022 · Issue price ₹73

₹136.00₹4.00 (2.86%)

Share price at the NSE close on 29 Oct 2026. Previous close ₹140.00.

29 Oct: open ₹140.00, high ₹140.00, low ₹136.00

52-week range of traded prices to 29 Oct 2026

₹134.00Low, 28 Oct 2026₹335.00High, 26 Dec 2025

Market cap: ₹143 Cr
P/E: 15.91
P/B: 1.99
Dividend yield: Nonein the last 12 months
ROE: 13.4%
Debt to equity: 0.04
Volume, NSE: 800100.0% delivered

Vaidya Sane Ayurved Laboratories disputes and clarifications

12 filed, newest first.

Jul 2026
- 20 Jul · Legal
  Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. -2. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is enclosed.
Jun 2026
- 11 Jun · Legal
  Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted in XBRL with discrepancies. -2. Financial results submitted is not as per format prescribed by SEBI. The response of the Company is awaited.
Apr 2026
- 28 Apr · Legal
  Significant movement in price has been observed in Vaidya Sane Ayurved Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Dec 2025
- 26 Dec · Legal
  Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
Jun 2025
- 23 Jun · Legal
  Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI -2. Segment details not submitted The response of the Company is awaited.
Apr 2025
- 25 Apr · Legal
  Significant movement in price has been observed in Vaidya Sane Ayurved Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Jul 2024
- 2 Jul · Legal
  Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed.
Jun 2024
- 20 Jun · Legal
  Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
Jul 2023
- 4 Jul · Legal
  Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed.
Jun 2023
- 20 Jun · Legal
  Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -2. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
May 2022
- 16 May · Legal
  Exchange had sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Segment details not submitted The response of the Company is enclosed.
- 11 May · Legal
  Exchange has sought clarification from Vaidya Sane Ayurved Laboratories Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Segment details not submitted The response of the Company is awaited.

Vaidya Sane Ayurved Laboratories disputes and clarifications

Jul 2026

Jun 2026

Apr 2026

Dec 2025

Jun 2025

Apr 2025

Jul 2024

Jun 2024

Jul 2023

Jun 2023

May 2022